Schedule a Call

Blog

GLP-1 RA and SGLT2-I Adoption and Retention in Patients with Diabetes

Maria Muccioli, PhD

Maria Muccioli, PhD

Research Director

Research Reports

We've tapped into our patient database, comprising over 65,000 individuals living with diabetes, to understand how GLP-1 RAs and SGLT-2 Inhibitors are impacting patients weight loss, their sentiment towards the pharmaceutical companies making the treatments, and the correlation between cost and adherence.

What you get

Reliable data empowering your organization to confidently make strategic decisions. This report includes insights from:

  • 1,500+ US adults with type 2 diabetes

  • 40% non-white participants

  • 50% male / 50% female respondents

About the author

Maria Muccioli, PhD

Maria Muccioli, PhD

Research Director

Maria brings clinical research expertise to her work overseeing healthcare market research programs for Thrivable customers. She earned a PhD in Molecular and Cellular Biology from Ohio University and was also a postdoctoral researcher at the Ohio State University and a fellow at the Brigham and Women’s Hospital and Harvard Medical School.

people illustration 15
Who do you want to connect with?
people illustration 13